Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
9,924 results
- CONNECT-IBDIndependent statistical analysis of Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Connected Healthcare for Individuals Living at Home With Chronic Conditions: Complete Statistical AnalysisIndependent statistical analysis of Connected Healthcare for Individuals Living at Home With Chronic Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04339296).
- ConNicBrainIndependent statistical analysis of Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01406223).
- CONSENSUS IIIndependent statistical analysis of A Clinical Evaluation of the Sinexus Intranasal Splint Following Functional Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CONSERVAIndependent statistical analysis of Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Conservative Treatment of Postprostatectomy Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Conservative Treatment of Postprostatectomy Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00212264).
- Consistency Lots Vaccine Study (V260-009): Complete Statistical AnalysisIndependent statistical analysis of Consistency Lots Vaccine Study (V260-009): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00092456).
- Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior: Complete Statistical AnalysisIndependent statistical analysis of Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ConstellationIndependent statistical analysis of BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ConsultaTM CRT-D Clinical Evaluation Study: Complete Statistical AnalysisIndependent statistical analysis of ConsultaTM CRT-D Clinical Evaluation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00526162).
- Contact: Developing New Clinical Management Strategies: Complete Statistical AnalysisIndependent statistical analysis of Contact: Developing New Clinical Management Strategies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03812588).
- CONTAINIndependent statistical analysis of Inhaled Ciclesonide for Outpatients With COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435795).
- Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer:…
- Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01165775).
- Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320069).
- Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717977).
- Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week: Complete Statistical AnalysisIndependent statistical analysis of Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Continuous Lidocaine Infusion for Management of Perioperative Burn Pain: Complete Statistical AnalysisIndependent statistical analysis of Continuous Lidocaine Infusion for Management of Perioperative Burn Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02059902).
- Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: Complete Statistical AnalysisIndependent statistical analysis of Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CONTRAIL IIndependent statistical analysis of Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension: primary…
- contRAst 2Complete statistical analysis of the phase 3 contRAst 2 trial of GSK3196165 (otilimab) versus placebo and tofacitinib in moderately to severely active rheumatoid arthritis.
- Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Contrast-enhanced Ultrasound Evaluation of Chemoembolization: Complete Statistical AnalysisIndependent statistical analysis of Contrast-enhanced Ultrasound Evaluation of Chemoembolization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02764801).
- CONTROLIndependent statistical analysis of Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00184548).
- Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): Complete Statistical AnalysisIndependent statistical analysis of Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: Complete Statistical AnalysisIndependent statistical analysis of Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Convalescent Plasma vs. Standard Plasma for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Convalescent Plasma vs. Standard Plasma for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04344535).
- Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).
- Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COOLIndependent statistical analysis of A Proof of Concept Study to Investigate the Use and Relevance of a Digital Platform for Infant Crying and Fussing: primary endpoint results, effect estimate with confidence interval,…
- Cooling Vest May Reduce Heat Stress During Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cooling Vest May Reduce Heat Stress During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04511208).
- Coordinated Emergency Department Transitions: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Emergency Department Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06933849).
- Coordinated Oral Health Promotion (CO-OP) Chicago: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Oral Health Promotion (CO-OP) Chicago: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03397589).
- Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COPEIndependent statistical analysis of A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- COPE-HCVIndependent statistical analysis of Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: Complete Statistical AnalysisIndependent statistical analysis of CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00889265).
- Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Corneal Nerves Function and Structure: Complete Statistical AnalysisIndependent statistical analysis of Corneal Nerves Function and Structure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222660).
- Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: Complete Statistical AnalysisIndependent statistical analysis of Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00353795).
- Coronary MDCTA With Iopamidol Injection 370: Complete Statistical AnalysisIndependent statistical analysis of Coronary MDCTA With Iopamidol Injection 370: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00558792).